<?xml version='1.0' encoding='UTF-8' standalone='no'?>
<rdf:RDF xmlns:dc="http://dublincore.org/specifications/dublin-core/dcmi-terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:bqbiol="http://biomodels.net/biology-qualifiers/" xmlns:collex="http://www.collex.org/schema#" xmlns:bqmodel="http://biomodels.net/model-qualifiers/" xmlns:scoro="http://purl.org/spar/scoro/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:title>Wang, Lin, Lin, Wu, 2008</dc:title>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <prism:keyword>muscle</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <prism:keyword>electrophysiology</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <prism:keyword>pharmacology</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <prism:keyword>skeletal</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:description>Model Status

            This model runs in both PCEnv and COR. It does not recreate the published results, because the published paper had an incorrect equation for I_Ca, which is corrected in this model after consultation with the model authors. In this model, I_Ca has the term (V_m - E_Ca) included to correct the model.   
          
Model Structure

Abstract: Riluzole is known to be of therapeutic use in the management of amyotrophic lateral sclerosis. In this study, we investigated the effects of riluzole on ion currents in cultured differentiated human skeletal muscle cells (dHSkMCs). Western blotting revealed the protein expression of greek small letter alpha-subunits for both large-conductance Ca2+-activated K+ (BKCa) channel and Na+ channel (Nav1.5) in these cells. Riluzole could reduce the frequency of spontaneous beating in dHSkMCs. In whole-cell configuration, riluzole suppressed voltage-gated Na+ current (INa) in a concentration-dependent manner with an IC50 value of 2.3 uM. Riluzole (10 uM) also effectively increased Ca2+-activated K+ current (IK(Ca)) which could be reversed by iberiotoxin (200 nM) and paxilline (1 uM), but not by apamin (200 nM). In inside-out patches, when applied to the inside of the cell membrane, riluzole (10 uM) increased BKCa-channel activity with a decrease in mean closed time. Simulation studies also unraveled that both decreased conductance of INa and increased conductance of IK(Ca) utilized to mimic riluzole actions in skeletal muscle cells could combine to decrease the amplitude of action potentials and increase the repolarization of action potentials. Taken together, inhibition of INa and stimulation of BKCa-channel activity caused by this drug are partly, if not entirely, responsible for its muscle relaxant actions in clinical setting. 


The complete original paper reference is cited below:


Effect of riluzole on action potential in cultured human skeletal muscle cells, Ya-Jean Wang, Ming-Wei Lin, An-An Lin, Sheng-Nan Wu, 2007, Life Sciences, 82, 11-20. PubMed ID: 18068197 
</dc:description>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <dc:identifier rdf:resource="None">None</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <rdfs:label>PMR workspace</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:source rdf:resource="local:00001">local:00001</dc:source>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <rdfs:label>Ya-Jean Wang</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <foaf:name>Ya-Jean Wang</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:creator rdf:resource="local:00002">local:00002</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <rdfs:label>Ming-Wei Lin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <foaf:name>Ming-Wei Lin</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:creator rdf:resource="local:00003">local:00003</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <rdfs:label>An-An Lin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <foaf:name>An-An Lin</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:creator rdf:resource="local:00004">local:00004</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00005">
    <rdfs:label>Sheng-Nan Wu</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00005">
    <foaf:name>Sheng-Nan Wu</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:creator rdf:resource="local:00005">local:00005</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00006">
    <dc:identifier rdf:resource="https://creativecommons.org/licenses/by/3.0/">https://creativecommons.org/licenses/by/3.0/</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00006">
    <rdfs:label>ccby</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/3a4c502f78a8c3a5845844b501e153e9.omex">
    <dc:license rdf:resource="local:00006">local:00006</dc:license>
  </rdf:Description>
</rdf:RDF>
